Altor Licenses T-Cell Receptors Targeting HIV and HCV From MGH
Posted on: Thursday, 11 September 2008, 09:00 CDT
Altor BioScience has entered into an agreement with Massachusetts General Hospital for exclusive, worldwide rights to develop and commercialize T-cell receptors specific for cells infected by HIV and hepatitis C virus.
The license has resulted from the success of Altor's collaboration established in 2004 with Howard Hughes Medical Institute and the Partners AIDS Research Center at Massachusetts General Hospital (MGH). Altor has already successfully improved and converted the licensed T-cell receptors (TCRs) into targeted therapeutic reagents using its Soluble T-cell Antigen Receptor (STAR) technology.
Hing Wong, president and CEO of Altor, said: "The receptors we have licensed were discovered and characterized by Bruce Walker, one of the foremost authorities on viral antigen expression and T-cell immune responses in HIV and hepatitis C virus (HCV) patients.
"We are excited to have the opportunity to add these targeting molecules to our STAR program and look forward to taking an anti-HIV and anti-HCV drug candidate into the clinic. The specific targeting to HIV-infected cells makes it possible for the first time to eliminate latent viral reservoirs, which cannot be achieved with currently available treatments."
Source: Datamonitor
Related Articles
- Drug May Shrink Breast Cancers
- Potent Peptides Inhibit HIV Cell Entry
- Scientists Make HIV T-Cells Breakthrough
- Altor BioScience Introduces STAR(TM) Multimer Reagents to Measure Disease-Specific Antigen Presentation
- Synthetic protein eases arthritis symptoms in mice
- Decreased Breast Cancer Survival Associated with High TRAIL-R2 Expression
- The Role of Herpesvirus Entry Mediator As a Negative Regulator of T Cell-Mediated Responses
- C-Cbl-Deficient Mice Have Reduced Adiposity, Higher Energy Expenditure, and Improved Peripheral Insulin Action
- Genes Differentially Expressed in Activated B Cell Isolated By Substractive cDNA Hybridisation
- Remarkably Similar Antigen Receptors Among a Subset of Patients With Chronic Lymphocytic Leukemia
 |
 |
User Comments (0)
RSS Feeds